Compounds > amifostine anhydrous

amifostine anhydrous and imatinib mesylate

amifostine anhydrous has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blasiak, J; Drzewoski, J; Gloc, E; Pertyński, T1
González-Cid, M; Larripa, I; Nebel, Mde C; Vellón, L1
Bianchini, M; Gonzalez Cid, M; Larripa, I; Martinelli, G; Renzulli, M1

Other Studies

3 other study(ies) available for amifostine anhydrous and imatinib mesylate

ArticleYear
DNA damage and repair in BCR/ABL-expressing cells after combined action of idarubicin, STI571 and amifostine.
    Anti-cancer drugs, 2002, Volume: 13, Issue:10

    Topics: Amifostine; Animals; Antineoplastic Agents; Benzamides; Cell Line, Transformed; Cell Survival; Comet Assay; DNA Damage; DNA Repair; Drug Combinations; Fusion Proteins, bcr-abl; Idarubicin; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Rats

2002
Additive apoptotic effect of STI571 with the cytoprotective agent amifostine in K-562 cell line.
    Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:6

    Topics: Amifostine; Antineoplastic Agents; Antioxidants; Apoptosis; Benzamides; Cell Cycle; Cell Proliferation; Comet Assay; Cytoprotection; Drug Screening Assays, Antitumor; Drug Synergism; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Membrane Potentials; Mitochondria; Piperazines; Pyrimidines

2005
cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib.
    Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:3

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Survival; DNA-Binding Proteins; Drug Combinations; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; K562 Cells; Oligonucleotide Array Sequence Analysis; Piperazines; Pyrimidines; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Tumor Suppressor Proteins

2007